ResMed Inc Chess Depository Interest RSMDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $24.53
- Day Range
- $22.61–22.61
- 52-Week Range
- $11.85–37.91
- Bid/Ask
- $21.02 / $26.05
- Shares Outstanding
- 1.41B
- Market Cap
- $32.80B
- Volume/Avg
- 1,736 / 1,225
Key Statistics
- Price/Earnings (Normalized)
- 20.24
- Price/Sales
- 5.84
- Dividend Yield (Trailing)
- 1.09%
- Dividend Yield (Forward)
- 1.17%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 2.98%
Company Profile
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,370
- Website
- https://www.resmed.com
Competitors
Valuation
|
Metric
|
RSMDF
|
CTEC
|
COLO B
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.24 | 23.76 | 35.10 |
Price/Book Value | 4.95 | 4.18 | 7.69 |
Price/Sales | 5.84 | 2.47 | 3.61 |
Price/Cash Flow | 17.56 | 13.35 | 13.12 |
Price/Earnings
RSMDF
CTEC
COLO B
Financial Strength
|
Metric
|
RSMDF
|
CTEC
|
COLO B
|
|---|---|---|---|
Quick Ratio | 1.83 | 1.06 | 0.88 |
Current Ratio | 3.10 | 1.93 | 1.56 |
Interest Coverage | — | 3.34 | 6.65 |
Quick Ratio
RSMDF
CTEC
COLO B
Profitability
|
Metric
|
RSMDF
|
CTEC
|
COLO B
|
|---|---|---|---|
Return on Assets (Normalized) | 19.09% | 9.54% | 11.86% |
Return on Equity (Normalized) | 25.91% | 22.72% | 38.99% |
Return on Invested Capital (Normalized) | 22.30% | 13.15% | 15.76% |
Return on Assets
RSMDF
CTEC
COLO B
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|$>^W$@J | LOCK|wyp | $149B | |||
| Becton Dickinson & Co
BDX
| LOCK|x@r | LOCK|sm$Tk | $51B | |||
| ResMed Inc
RMD
| LOCK|<#?Gk&rj | LOCK|Tb<G | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|$<SCj% | LOCK|C&nZ | $31B | |||
| Alcon Inc
ALC
| LOCK|<S#Zxt! | LOCK|^rxV | $30B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|@dH%<w$d | LOCK|Yf | $26B | |||
| Solventum Corp
SOLV
| LOCK|$?KWSTp | LOCK|#&@ | $15B | |||
| Baxter International Inc
BAX
| LOCK|Ng | LOCK|q^tH | $13B | |||
| Repligen Corp
RGEN
| LOCK|$%&??K?M | LOCK|%#!Nt | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|Lp!?<Bl | LOCK|bHVN^ | $10B |
United States